(Q33827802)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

0 references

1 reference

Yuhua Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Lei Miao

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Zhenghong Xu

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ching-Hsuan M Lin

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

8 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

7647-7653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy

20 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Cisplatin protects against acute liver failure by inhibiting nuclear HMGB1 release

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Doxil®--the first FDA-approved nano-drug: lessons learned

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Biomineralization and size control of stable calcium phosphate core-protein shell nanoparticles: potential for vaccine applications

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Cellular responses to Cisplatin-induced DNA damage

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Cisplatin nephrotoxicity: a review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Cisplatin and platinum drugs at the molecular level. (Review)

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4076841

Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24920436

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24920436

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activity of paclitaxel liposome formulations against human ovarian tumor xenografts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24920436

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.BIOMATERIALS.2014.05.045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24920436%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

24920436

1 reference